Off-label application of intravenous immunoglobulin (IVIG) for treatment of Cogan's syndrome during pregnancy

4Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

We report the case of a woman with Cogan's syndrome concomitant with the wish to have children. After three major flares of the disease that led to unilateral deafness, immunosuppressive therapy with prednisolone and azathioprine was started. Because of the severe side effects, an off-label therapy with intravenous immunoglobulin (IVIG) was initiated, under which our patient has since given birth to three healthy children. To our knowledge this is the first report to describe Cogan's syndrome with multiple successful pregnancies under IVIG treatment.

Cite

CITATION STYLE

APA

Scherg, F., Haag, F., & Krieger, T. (2019, October 1). Off-label application of intravenous immunoglobulin (IVIG) for treatment of Cogan’s syndrome during pregnancy. BMJ Case Reports. BMJ Publishing Group. https://doi.org/10.1136/bcr-2018-227917

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free